
Click on each section you wish to purchase
Click on add to cart to add all the sections in shopping cart
Click on the cart to proceed to payment
Click on Checkout to complete the final checkout
Executive Summary
Summary
Syncom BV (Syncom) is a provider of custom synthesis solutions. The company's activities include synthesis of key building blocks, route scouting services, process research activities and medicinal chemistry services. Its service portfolio includes contract research services, chiral technology services, medicinal chemistry services and analytical services. The company also offers customized service such as synthesize metabolites, impurities, reference standards and stable labelled compounds. The company's services support both the pharmaceutical and chemical industries across the globe. Its chiral technologies include resolution of racemates, chiral chromatography, preferential crystallization, chiral pool synthesis, conglomerate screening and enzymatic catalysis. Syncom is headquartered in Groningen, the Netherlands.
Syncom BV-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Syncom BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Syncom BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Syncom BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Syncom BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Syncom BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Syncom BV, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AGILeBiotics Enters into Agreement with Syncom 10
Austin Chemical, Syncom and ChemConnection Form Joint Venture 11
Syncom Enters into Agreement with AXIM Biotech 12
Merger 13
Mercachem and Syncom Merge 13
Syncom BV-Key Competitors 14
Syncom BV-Key Employees 15
Syncom BV-Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List of Figures
Syncom BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Syncom BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Syncom BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Syncom BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Syncom BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Syncom BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Syncom BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Syncom BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Tables
Syncom BV, Pharmaceuticals & Healthcare, Key Facts 2
Syncom BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Syncom BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Syncom BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Syncom BV, Deals By Therapy Area, 2012 to YTD 2018 8
Syncom BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AGILeBiotics Enters into Agreement with Syncom 10
Austin Chemical, Syncom and ChemConnection Form Joint Venture 11
Syncom Enters into Agreement with AXIM Biotech 12
Mercachem and Syncom Merge 13
Syncom BV, Key Competitors 14
Syncom BV, Key Employees 15
Syncom BV, Joint Venture 16
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Syncom BV, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
For Regular updates on our latest research reports
Compare